SCHEMBL7696698

SCHEMBL7696698

N#Cc1cc(F)c(Cl)cc1OC1(C(F)(F)F)CNC1

nearest known ligand 0.39

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 2/20 0.39
▸ SLC6A2 P23975 2/20 0.39
▸ SLC6A4 P31645 2/20 0.39
▸ NOS2 P35228 2/20 0.39
▸ ALDH1A1 P00352 1/20 0.36
▸ BCL2A1 Q16548 1/20 0.34
▸ BCAT2 O15382 2/20 0.32
▸ BCAT1 P54687 2/20 0.32
▸ SLC22A12 Q96S37 1/20 0.32
▸ MRGPRX4 Q96LA9 1/20 0.32
▸ AR P10275 4/20 0.32
▸ MGAT2 Q10469 1/20 0.31
▸ KHK P50053 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7695431 0.99 CYP2D6 (0.38) CYP2D6SLC6A2SLC6A4NOS2ALDH1A1
SCHEMBL7693162 0.78 BCL2A1 (0.39) CYP2D6SLC6A2SLC6A4NOS2ALDH1A1
SCHEMBL7695111 0.76 BCL2A1 (0.40) CYP2D6SLC6A2SLC6A4NOS2ALDH1A1
Hydrochloric Acid SCHEMBL7696821 0.75 BCL2A1 (0.40) CYP2D6SLC6A2SLC6A4NOS2ALDH1A1
SCHEMBL7701147 0.74 GPR119 (0.41) CYP2D6SLC6A2SLC6A4NOS2BCL2A1
SCHEMBL30718081 0.73 CYP2D6 (0.42) CYP2D6SLC6A2SLC6A4NOS2ALDH1A1
SCHEMBL31261067 0.73 CYP2D6 (0.42) CYP2D6SLC6A2SLC6A4NOS2ALDH1A1
SCHEMBL7693272 0.72 CYP2D6 (0.36) CYP2D6SLC6A2SLC6A4NOS2ALDH1A1
SCHEMBL7690785 0.72 CYP2D6 (0.39) CYP2D6SLC6A2SLC6A4NOS2ALDH1A1
Hydrochloric Acid SCHEMBL7696294 0.72 CYP2D6 (0.38) CYP2D6SLC6A2SLC6A4NOS2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002012187-A1 NOVEL PHENYLHETEROAZETIDINES, USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS ASTRAZENECA AB (SE) 2002-02-14 — — WO disclosed
Send feedback